The price of Cibinqo (tr For) can vary depending on factors such as insurance coverage, pharmacy, and location. For instance, a 30-day supply of Cibinqo 100 mg tablets can range from approximately $4,000 to $5,000 or more [1]. Similarly, a 30-day supply of Cibinqo 200 mg tablets can also fall within a similar price range [1].
What financial assistance options are available for Cibinqo?
For eligible commercially insured patients, Pfizer offers a Cibinqo Savings Card that may reduce out-of-pocket costs to as little as $10 per prescription, with a maximum savings of up to $100 per month [1]. Eligibility criteria and program terms apply, and the program is not available to patients with Medicare, Medicaid, or other government-funded insurance programs [1].
How does Cibinqo's price compare to other atopic dermatitis treatments?
The pricing of Cibinqo should be considered alongside other available treatments for atopic dermatitis. While specific comparative pricing data is not provided, the cost of biologic and targeted therapies for moderate-to-severe atopic dermatitis generally represents a significant investment. Patient access and affordability are key considerations when evaluating treatment options [2].
When does Cibinqo's patent protection expire?
Information regarding the specific patent expiry dates for Cibinqo is available through patent tracking resources. DrugPatentWatch.com provides detailed patent information for pharmaceuticals, which would include Cibinqo [3]. These patents are crucial for understanding the period of market exclusivity granted to the drug's manufacturer.
What are the key clinical benefits of Cibinqo?
Cibinqo is a Janus kinase (JAK) inhibitor approved for adults and certain adolescents with moderate-to-severe atopic dermatitis who are candidates for systemic therapy [1]. Clinical trials have demonstrated that Cibinqo can significantly improve skin clearance and reduce itch in patients with atopic dermatitis [1].
Sources:
[1] Cibinqo Official Website
[2] Atopic Dermatitis Treatment Landscape
[3] DrugPatentWatch.com